Concepedia

Willy P. Burkard

WP

10

Publications

505

Citations

10

H-Index

1958

Active since

Affiliations

Roche (Switzerland)(Current)

University of Basel

Universität Innsbruck

Willy P. Burkard is an author at Roche (Switzerland) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1958–1998

10

Publications

10

Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum

Karl H. Baureithel, Karin Berger Büter, Anja Engesser et al. · Pharmaceutica Acta Helvetiae · 1997 · 105 citations

, , +8

Ro 15-4513: Partial inverse agonism at the BZR and interaction with ethanol

E. P. Bonetti, Willy P. Burkard, M. Gabl et al. · Pharmacology Biochemistry and Behavior · 1988 · 93 citations

, , +3

Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(Cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective .mu. opioid receptor antagonist

Helmut Schmidhammer, Willy P. Burkard, Lislott Eggstein‐Aeppli et al. · Journal of Medicinal Chemistry · 1989 · 83 citations · Full text

Histamine H2-receptor binding with 3H-cimetidine in brain

Willy P. Burkard · European Journal of Pharmacology · 1978 · 78 citations

, , +6

Verapamil, an antagonist at 5-Hydroxytryptamine receptors of human blood platelets

Hubert Affolter, Willy P. Burkard, A. Pletscher · European Journal of Pharmacology · 1985 · 40 citations

, , +11

Rows per page

1–5 of 10